在脂肪生成过程中,PAK4可化循环林依赖性激酶2以促进G1/S过渡
Hwang Chan Yu1, Su Hyeon Park1, Hye Jin Jo2
1Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
Experimental & molecular medicine
|September 29, 2025
概括
21激活酶4 (PAK4) 对于脂肪细胞的分化至关重要,影响脂肪质量. 这一发现凸显了PAK4作为肥胖治疗的潜在治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 代谢过程中的代谢.
- 分子生物学分子生物学
背景情况:
- 21激活激酶4 (PAK4) 以其在瘤发育中的作用而闻名.
- 最近的研究确定了PAK4在脂肪细胞中的三糖醇脂解中的参与.
- 之前,PAK4在脂肪生成中的作用尚不清楚.
研究的目的:
- 研究PAK4在脂肪细胞分化中的作用.
- 阐明PAK4调节脂肪生成的分子机制.
- 评估针对PAK4治疗肥胖症的治疗潜力.
主要方法:
- 在基刺激期间研究了PAK4蛋白水平.
- 在3T3-L1前脂质细胞和人体管血管细胞中利用了PAK4敲击.
- 在3T3-L1细胞中使用PAK4的药理抑制.
- 分析了脂肪细胞标记物基因表达和脂质积累.
- 研究了PAK4对循环林依赖性激酶2 (CDK2) 的酸化.
- 在预脂细胞特异性Pak4-Knockout小鼠中检查了脂肪质量和脂肪细胞大小.
主要成果:
- 在基刺激后,PAK4蛋白水平增加.
- 阻断或抑制PAK4损害了脂肪生成,减少了脂肪细胞标记物基因表达和脂质积累.
- 发现PAK4在血清106上化CDK2,这是CCAAT/增强剂结合蛋白β表达在线粒细胞克隆扩张期间的关键步骤.
- 预脂细胞特异性Pak4淘汰赛小鼠显示脂肪质量减少和脂肪细胞较小.
结论:
- PAK4在调节脂肪细胞分化方面发挥着至关重要的作用.
- PAK4在促进脂肪生成方面的功能,以及其在脂解中的抑制作用,使其成为肥胖治疗的重要目标.
相关概念视频
02:39Positive Regulator Molecules
6.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.5K
01:45Positive Regulator Molecules
134.3K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
134.3K
01:25cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
01:22PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
02:15M-Cdk Drives Transition Into Mitosis
6.3K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.3K